ASGO Workshop 2020 Agenda
|
601 Room |
Topic |
Speaker |
Moderator |
|
09:20-09:25 |
Opening remarks of ASGO |
President: Dr.Daisuke Aoki |
|
|
09:25-09:30 |
Opening remarks of IGCS |
Vice President: Dr. Jae-Weon Kim |
|
|
09:30-09:35 |
Opening remarks of TAGO |
President: Dr. Chih-Ming Ho |
|
|
09:35-09:40 |
Time for Taiwan - My Beautiful Island |
||
|
09:40-10:20 |
Practice in gynecologic oncology during Covid 19 pandemics |
Dr. Hung-Cheng Lai |
|
|
Korea |
|||
|
Japan |
|||
|
India |
|||
|
Malaysia |
|||
|
Taiwan |
|||
|
10:20-10:50 |
Novel Immunotherapy for advanced endometrial cancer ( Industrial section) |
Dr. Lee-Wen Huang |
|
|
10:50-11:10 |
Update on cervical cancer surgery- abdominal or minimally invasive approach |
Dr. Kung-Liahng Wang |
|
|
11:10-11:20 |
Break |
||
|
11:20-11:40 |
Update on treatment of metastatic or relapsed cervical cancer |
Dr. Wen-Fang Cheng |
|
|
11:40-12:00 |
Radical trachelectomy for early stage cervical cancer at 15-17 weeks of gestation |
Dr. Hua-His Wu |
|
|
12:00-13:00 |
Lunch |
||
|
13:00-13:20 |
Anatomic dissection in nerve-sparing radical hysterectomy for cervical cancer |
Dr. Yiu-Tai Li |
|
|
13:20-13:40 |
Molecular characterization and its clinical implication in endometrial cancer |
Dr. Shih-Chu Ho |
|
|
13:40-13:50 |
Break |
||
|
13:50-14:10 |
Two-step sentinel lymph node mapping strategy in endometrial cancer staging |
Dr. Chiou-Chung Yuan |
|
|
14:10-14:30 |
Adjuvant therapy for early endometrial cancer- when and how and why? |
Dr. Ya-Min Cheng |
|
|
14:30-14:40 |
Break |
||
|
14:40-15:00 |
Treatment for stage 4 and metastatic endometrial cancer |
Dr. Chyong-Huey Lai |
|
|
15:00-15:20 |
Ovarian cancer surgery- 1st and 2nd debulking operation |
Dr. Hung-Hsueh Chou |
|
|
15:20-15:30 |
Break |
||
|
15:30-15:50 |
Personalized medicine- Maintenance therapy in ovarian cancer |
Dr. Chia-Yen Huang |
|
|
15:50-16:10 |
Treatment for relapsed ovarian cancer |
Dr. Pao-Ling Torng |
|
|
16:10-16:20 |
Break |
||
|
16:20-16:40 |
Current role of minimally invasive surgery for ovarian cancer |
Dr. Peng-Hui Wang |
|
|
16:40-17:00 |
Big data analysis in populational gynecologic oncology- methods and outcomes |
Dr. Wen-Shiung Liou |
|
|
17:00-17:10 |
Break |
||
|
17:10-17:30 |
Shared decision-making in real practice |
Dr. Hao, Lin |
|
|
17:30-17:35 |
The 7th ASGO Biennial Meeting See you in Thailand |
||
|
603 Room |
Topic |
Speaker |
Moderator |
|
09:20-09:25 |
Opening remarks of ASGO (601 Room) |
President: Dr.Daisuke Aoki |
|
|
09:25-09:30 |
Opening remarks of IGCS (601 Room) |
Vice President: Dr. Jae-Weon Kim |
|
|
09:30-09:35 |
Opening remarks of TAGO (601 Room) |
President: Dr. Chih-Ming Ho |
|
|
09:35-09:40 |
Time for Taiwan - My Beautiful Island (601 Room) |
||
|
09:40-10:20 |
Practice in gynecologic oncology during Covid 19 pandemics (601 Room) |
Dr. Hung-Cheng Lai |
|
|
Korea |
Dr. Sokbom Kang |
||
|
Japan |
Dr. Yusuke Kobayashi |
||
|
India |
Dr. Neerja Bhatla |
||
|
Malaysia |
Dr. Suresh Kumarasamy |
||
|
Taiwan |
Dr. Cheng-Chang Chang |
||
|
10:20-10:40 |
Precision medicine in gynecologic cancers |
Dr. Bor-Ching Sheu |
|
|
10:40-11:00 |
Mechanism targeting homologous recombination deficiencies in ovarian cancer |
Dr. Tze-Ho Chen |
|
|
11:00-11:10 |
Break |
||
|
11:10-11:30 |
Biomarker and genetic testing for PARP inhibitor |
Dr. Ming-Shyen Yen |
|
|
11:30-12:00 |
Safety and QoL of Avastin in Gyn cancer ( Industrial section) |
Dr. Yu-Min Ke |
|
|
12:00-12:30 |
SGO-ROC 10th Council meeting |
||
|
12:30-13:00 |
TAGO 9th Council meeting |
||
|
13:00-13:30 |
Evolving area of maintenance therapy in recurrent ovarian cancer ( Industrial section) |
Dr. Nae-Fang Twu |
|
|
13:30-13:50 |
PARP inhibitors in ovarian cancer |
Dr. Yao-Ching Hung |
|
|
13:50-14:00 |
Break |
||
|
14:00-14:20 |
Immuno-Oncology in Gynecological Malignancies |
Dr. Keng-Fu Hsu |
|
|
14:20-14:40 |
Biomarkers in Immuno-oncology for Gynecological Cancers |
Dr.Ting-Chang Chang |
|
|
14:40-14:50 |
Break |
||
|
14:50-15:10 |
Cell therapy in gynecologic cancers |
Dr. Lian-Shung Yeh |
|
|
15:10-15:40 |
Trabectedin in gynecological cancer ( Industrial section) |
Dr. Fu-Shing Liu |
|
|
15:40-15:50 |
Break |
||
|
15:50-16:20 |
What’s next for PARP inhibitors? PARPi resistance and ways to overcome ( Industrial section) |
Dr. Yuan-Yee Kan |
|
|
16:20-17:50 |
Young doctor Session / Oral Presentation |
Dr. Cheng-Yang Chou |
|
|
17:50-17:55 |
The 7th ASGO Biennial Meeting See you in Thailand |
||
ASGO Workshop 2020 Agenda
|
601 Room |
Topic |
Speaker |
Moderator |
|
09:30-10:00 |
The Origin of Ovarian Cancer Species and Precancerous Landscape |
Dr. Chih-Ming Ho |
|
|
10:00-10:30 |
Identification of BRCAness in clinical daily practice: genes, phenotypes, and cases ( Industrial section) |
Dr. Tang-Yuan Chu |
|
|
10:30-10:40 |
Break |
||
|
10:40-11:10 |
Optimize the chemotherapy in platinum-sensitive recurrent ovarian cancer and real world data in Taiwan ( Industrial section) |
Dr. Kuan-Chong Chao |
|
|
11:10-11:30 |
Update in the treatment for uterine sarcoma |
Dr. Yi-Jen Chen |
|
|
11:30-11:40 |
Break |
||
|
11:40-12:00 |
Laparoscopic hyperthermic intraperitoneal chemotherapy |
Dr. Mu-Hsien Yu |
|
|
12:00-12:20 |
Cancer during Pregnacy: a big challenge |
Dr. Chien-Hsing Lu |
|
|
12:20-12:25 |
The 7th ASGO Biennial Meeting See you in Thailand |
||
|
603 Room |
Topic |
Moderator |
|
09:30-11:00 |
Young doctor Session / Oral Presentation |
Dr. Peng-Hui Wang |
|
11:00-11:10 |
Break |
|
|
11:10-12:30 |
Young doctor Session / Oral Presentation |
Dr. Peng-Hui Wang |
|
12:30-12:35 |
The 7th ASGO Biennial Meeting See you in Thailand |
|